Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical bupivacaine + dexamethasone for post-tonsillectomy pain reduction
IRCT20181226042142N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Pain score at 12 hours, Pain score at 24 hours and 1 more. Started May 2019; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20181226042142N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181226042142N1.